YCBD — cbdMD, Inc. | ScreenerHero

YCBDcbdMD, Inc.

AMEX · US · Healthcare · Drug Manufacturers - Specialty & Generic

0.7599USD-0.14%Mkt Cap: 7.98M USDP/E: 0.31Last update: 2026-05-26

Industry Peers

Drug Manufacturers - Specialty & Generic

Swedish Orphan Biovitrum AB (publ)

155.29BSEKP/E 172.0

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.

58.11BTRYP/E 27.8

56.52BEURP/E 22.3

33.63BPLNP/E 21.9

United Therapeutics Corporation

24.50BUSDP/E 21.3

Neurocrine Biosciences, Inc.

15.76BUSDP/E 24.1

BioGaia AB (publ)

13.30BSEKP/E 40.0

Indicators:|

Key Statistics

Company

Market Cap7.98M USD

Enterprise Value—

Revenue (TTM)—

Gross Profit—

Net Income (TTM)—

Revenue/Share—

Last Price0.7599 USD

Fiscal Year End—

MR Quarter—

Employees—

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)0.31

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B—

EPS (TTM)—

EPS (Forward)—

52W Range

0.730083% of range0.7660

52W High0.7660 USD

52W Low0.7300 USD

Profitability

Gross Margin—

Oper. Margin—

EBITDA Margin—

Profit Margin—

ROE—

ROA—

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF—

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt—

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio—

Quick Ratio—

Book Value/Sh—

Cash/Share—

Dividends

Fwd Div Rate—

Trail. Div Rate—

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float—

Insiders—

Institutions—

Technical

SMA 50—

SMA 200—

Beta—

S&P 52W Chg—

Avg Vol (30d)112.38K

Avg Vol (10d)—

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—